Your landing page’s weakest score is Trust.
How Rani Therapeutics ranks
74Growth scoreupdated
category scores
category scoresShowHide
Trust
66FairProof that the product is real, competent, and safe to try.
| Trust read | |
|---|---|
| Rani Therapeutics | "3 Phase 1 studies completed" stat badge |
| "Columbia — University spinout technology" credential in the stats strip | |
| No visible trust signal identified. | |
| No visible trust signal identified. | |
| No visible trust signal identified. |
Information hierarchy
70FairDoes the design help or inhibit what the page is trying to say?
1234- Investors nav button — Darkest, highest-contrast element on the fold, outweighing the primary hero CTA and pulling first clicks into the nav.
- See how it works CTA — Washed mauve fill with white text reads as a disabled state next to the saturated Investors button.
- Seven-link nav row — Seven equal-weight exit links sit directly above the hero, each competing with the single desired action.
- Three-paragraph hero copy — Three same-weight paragraphs force reading instead of scanning and push the CTAs toward the fold line.
CTA
72FairCopy, size, verb, cost-feel — does the primary CTA earn the click?
How Rani Therapeutics compares
Recommended rewrites
Mobile web
79FairThe phone experience as a first-class citizen.
What works
What to improve
Value props
82StrongTitle, subtitle, hero — do they sell the product's true value?
Rani Therapeutics’s headline
Rani imagines a world without needles.
We are developing technology to enable orally administered biologics and drugs.
Working
Could improve